Adley Lab Limited - Due diligence report

A 360° intelligence report on Adley Labs: trust score, financial health, credit view, compliance, directors, growth and distress signals - g…

1992-04-10 Derabassi, Punjab Active Unlisted Active Compliant
Share
AL Adley Lab Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Adley Labs — 360° Intelligence Report

Generated from MCA filings & public records
90/100
Trust Score
Low Risk

Adley Labs is assessed as Low Risk with a Trust Score of 90/100. Adley Labs is an active public limited indian non-government company incorporated in 1992, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Adley Lab Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
90/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
78/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 3 open (30.01 cr) · 22 satisfied (22.04 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Hdfc Bank Limited1 48.0 cr
Bank Of India13 48.0 cr
Sidbi3 48.0 cr
Punjab National Bank3 48.0 cr
Vijaya Bank1 48.0 cr
Small Industries Development Bank Of India1 48.0 cr
Compliance Score: 78/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 2 court forum(s).
  • Delayed payments to MSME suppliers disclosed (99 disclosure(s)).
  • 1 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
RAHUL BATRA 01234567 Director 01/04/2018 6 yrs Approved
JAYANT KUMAR 01234567 Director 01/04/2018 6 yrs Approved
VARUN BATRA 01234567 Director 01/04/2018 6 yrs Approved
SEEMA CHOPRA 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2024 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Beta Drugs Limited
Subsidiaries
-
Group entities
-
Capital events
5 allotment(s) · 6 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Beta Drugs Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Latest year revenue grew 24%.
Profit expanded 0.86 year-on-year.
Asset base grew 61% - capacity expansion.
Net margin improved to 38%.
EPFO headcount growing - hiring signal.
Operating for 34+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
3 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 65,184.00.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence85/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment86/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 3 open charge(s) of 30.01 cr already registered.
  • Compliance record supports lending.
Investor view94/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 6 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
13 May 2025
Charge created
Axis Bank Limited - 31.30 Lakh
31 Mar 2025
Latest balance sheet
Filed with ROC
06 Feb 2025
Director appointed
SEEMA CHOPRA (Additional Director)
02 Jan 2024
Charge satisfied
Others
30 Nov 2023
Charge satisfied
Sidbi
12 Jul 2023
Charge created
Sidbi - 80.00 Lakh
07 May 2022
Charge created
Others - 12.50 Lakh
31 Mar 2022
Share transfer (FY 2022)
1.00000000 shares to ADITI BATRA
23 Jan 2021
Director ceased
VIJAY KUMAR BATRA
23 Oct 2020
Charge satisfied
Vijaya Bank
08 Oct 2020
Charge created
Hdfc Bank Limited - 28.90 cr
22 May 2020
Charge created
Sidbi - 37.00 Lakh
30 Sep 2019
Director ceased
RAHUL BATRA
Director ceased
VARUN BATRA
10

Key Observations

Auto-generated from the data above
Revenue grew 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Debt-to-equity stands at 0.86 - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
4 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Capital has been raised through 5 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Mamta Texdyes Private Limited U24113MH2004PTC357920 Mumbai, Maharashtra, India
Merril Pharma Private Limited U24230GJ2005PTC046638 Ahmedabad, Gujarat, India
Samrvir Biotech Private Limited U24303HR2019PTC082136 Gurgaon, Haryana, India
Gentech Healthcare Private Limited U85110DL2004PTC126874 New Delhi, Delhi, India
Solistaa Pharmaceuticals Private Limited U24304PY2017PTC008222 Pondicherry, Pondicherry, India
Evolet Pharmaceuticals Private Limited U24230HR2005PTC127251 Bhorakalan, Haryana, India
Custom Capsules Private Limited U24235MH1988PTC048924 Mumbai, Maharashtra, India
Thinq U24239MH2006PLC165473 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Adley Labs before audits and certifications: compliance score 78/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Adley Labs: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Adley Labs - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 90/100, distress signals and MSME payment-delay disclosures - know whether Adley Labs pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Adley Labs - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Adley Labs an active company?

Adley Labs has MCA status “Active” with a compliance score of 78/100 (Low Risk).

Is Adley Labs financially healthy?

Adley Labs has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Adley Labs?

Its overall Trust Score is 90/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Adley Labs?

The ultimate holding entity is Beta Drugs Limited. 4 active director(s) are on record.

Does Adley Labs have loans or charges against its assets?

3 open charge(s) are registered against its assets, and 22 earlier charge(s) stand satisfied.

Is Adley Labs up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 78/100 (Low Risk).

Is it risky to lend to Adley Labs?

Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.